Диссертация (1140518), страница 24
Текст из файла (страница 24)
– Vol.8. – №6. – Р.8450-71.163.Lienhart, A. Survey of anesthesia-related mortality in France / A. Lienhart, Y. Auroy, F.Pequignot [et al.] // Anesthesiology. – 2006. – Vol.105. – №6. – Р.1087–97.164.Link, R.E. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypesb and c / R.E. Link, K.
Desai, L. Hein [et al.] // Science. – 1996. – Vol.273. – №5276. – P.803–5.165.Lymperopoulos, A. Physiology and pharmacology of the cardiovascular adrenergic system/ A. Lymperopoulos // Front Physiol. – 2013. – Vol.4. – Р.240.166.Овечкин, А.М. 2015 Осипова, Н.А. 2002 Lynch, M.E. 2001 Antidepressants asanalgesics: a review of randomized controlled trials / M.E.
Lynch // J Psychiat Neurosci. – 2001. –Vol.26. – №1. – P.30-6.167.Ma, D. Alpha-2-Adrenoceptor agonists: shedding light on neuroprotection? / D. Ma, N.Rajakumaraswamy, M. Maze // Br Med Bull. – 2005. – Vol.71. – Р.77–92.109168.MacDonald, E. Gene targeting – homing in on alpha 2-adrenoceptor-subtype function / E.MacDonald, B.K. Kobilka, M. Scheinin // Trends Pharmacol Sci. – 1997.
– Vol.18. – №6. – Р.211–9.169.Mack, P.F. Dexmedetomidine and neurocognitive testing in awake craniotomy / P.F. Mack,K. Perrine, E. Kobylarz [et al.] // J Neurosurg Anesthesiol. – 2004. – Vol.16. – №1. – Р.20-5.170.MacMillan, L.B. Central hypotensive effects of the alpha2a-adrenergic receptor subtype /L.B. MacMillan, L. Hein, M.S. Smith [et al.] // Science. – 1996. – Vol.273. – №5276. – P.801-3.171.Makaritsis, K.P. Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension / K.P.
Makaritsis, D.E. Handy, C. Johns [et al.] // Hypertension. – 1999. –Vol.33. – №1. – Р.14–7.172.Malmberg, A.B. Contribution of α2 receptor subtypes to nerve injuryinduced pain and itsregulation by dexmedetomidine / A.B. Malmberg, L.R. Hedley, J.R. Jasper [et al.] // Br J Pharmacol.– 2001. – Vol.132. – №8. – Р.1827–36.173.Mangano, D.T.
Perioperative cardiac morbidity / D.T. Mangano // Anesthesiology. – 1990.– Vol.72. – №1. – Р.153–84.174.Mann, C. The relationship among carbon dioxide pneumoperitoneum, vasopressin releaseand hemodynamic changes / C. Mann, G. Boccara, Y. Pouzeratte [et al.] // Anesth Analg. – 1999. –Vol.89. – №2. – P.278-83.175.Manne, G.R.
Effects of low dose dexmedetomidine infusion on haemodynamic stressresponse, sedation and post-operative analgesia requirement in patients undergoing laparoscopiccholecystectomy / G.R. Manne, M.R. Upadhyay, V. Swadia // Indian J Anaesth. – 2014. – Vol.58. –№6. – Р.726-31.176.Mansikka, H. α2A-Adrenoceptors contribute to feedback inhibition of capsaicin-inducedhyperalgesia / H. Mansikka, J. Lаhdesmаki, M. Scheinin [et al.] // Anesthesiology. – 2004. – Vol.101.– №1. – Р.185–90.177.Martin, E.
Perioperative sympatholysis. Beneficial effects of the alpha 2-adrenoceptoragonist mivazerol on hemodynamic stability and myocardial ischemia / E. Martin, McSPI-EuropeResearch Group // Anesthesiology. – 1997. – Vol.86. – №2. – Р.346-63.178.Millar, J. Effect of iontophoresis of noradrenaline and stimulation of the periaqueductalgray on single-unit activity in the rat superficial dorsal horn / J. Millar, G.V. Williams // J CompNeurol. – 1989. – Vol.287.
– №1. – Р.119–33.179.Milstein, J.A. Selective depletion of cortical noradrenaline by anti ‑ dopamine beta ‑hydroxylase‑saporin impairs attentional function and enhances the effects of guanfacine in the rat /110J.A. Milstein, O. Lehmann, D.E. Theobald [et al.] // Psychopharmacology (Berl). – 2007. – Vol.190.– №1. – Р.51-63.180.Morton, C.R. Morphine does not reduce the intraspinal release of calcitonin gene-relatedpeptide in the cat / C.R. Morton, W.D.
Hutchison // Neurosci. Lett. – 1990. – Vol.117. – №3. – Р.319–24.181.Murata, K. Intrathecal clonidine suppresses noxiously evoked activity of spinal widedynamic range neurons in cats / K. Murata, I. Nakagawa, Y. Kumeta [et al.] // Anesth Analg. – 1989.– Vol.69. – №2. – Р.185-91.182.Muzi, M. Clonidine reduces sympathetic activity but maintains baroreflex responses innormotensive humans / M. Muzi, D.R. Goff, J.P.
Kampine [et al.] // Anesthesiology. – 1992. – Vol.77.– №5. – Р.864-71.183.Naaz, S. Dexmedetomidine in current anaesthesia practice - a review / S. Naaz, E. Ozair //J Clin Diagn Res. – 2014. – Vol.8. – №10. – GE01-4.184.Nelson, L.E. Evidence that the mechanism of hypnotic action in dexmedetomidine andmuscimol-induced anesthesia converges on the endogenous sleep pathway / L.E. Nelson, T. You, M.Maze [et al.] // Anesthesiology. – 2001. – Vol.95. – Р.A1368.185.Ohtani, N.
Recovery profiles from dexmedetomidine as a general anesthetic adjuvant inpatients undergoing lower abdominal surgery / N. Ohtani, K. Kida, K. Shoji [et al.] // Anesth Analg.– 2008. – Vol.107. – №6. – Р.1871-4.186.Ossipov, M.H. A comparison of the antinociceptive and behavioral effects of intrathecallyadministered opiates, alpha-2-adrenergic agonists, and local anesthetics in mice and rats / M.H.Ossipov, L.J. Suarez, T.C. Spaulding // Anesth Analg. – 1988.
– Vol.67. – №7. – Р.616-24.187.Overland, A.C. Protein kinase C mediates the synergistic interaction between agonistsacting at alpha2-adrenergic and delta-opioid receptors in spinal cord / A.C. Overland, K.F. Kitto, A.J.Chabot-Dorе [et al.] // J Neurosci. – 2009. – Vol.29. – №42. – Р.13264-73.188.Ozkose, Z. Hemodynamic and anesthetic advantages of dexmedetomidine, an alpha 2-agonist, for surgery in prone position / Z. Ozkose, F.S. Demir, K.
Pampal [et al.] // Tohoku J ExpMed. – 2006. – Vol.210. – №2. – P.153-60.189.Paalzow, L. Analgesia produced by clonidine in mice and rats / L. Paalzow // J. Pharm.Pharmacol. – 1974. – Vol.26. – №5. – Р.361-3.190.Panzer, О. Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil,ketamine, volatile anesthetics, and the role of peripheral mu antagonists / O.
Panzer, V. Moitra, R.N.Sladen // Anesthesiology clinics. – 2011. – Vol29. – №.4. – Р.587-605.111191.Paranjpe, J.S. Dexmedetomidine: Expanding role in anesthesia / J.S. Paranjpe // Med J DYPatil Univ. – 2013. – Vol.6. – №1. – Р.5-13.192.Pascoe, P.J. The cardiopulmonary effects of dexmedetomidine infusions in dogs duringisoflurane anesthesia / P.J. Pascoe // Vet Anaesth Analg. – 2015.
– Vol.425. – №4. – Р.360-8.193.Penttilä, J. Cardiovascular and parasympathetic effects of dexmedetomidine in healthysubjects / J. Penttilä, A. Helminen, M. Anttila [et al.] // Can J Physiol Pharmacol. – 2004. – Vol.82.– №5. – Р.359-362.194.Pertovaara, A. Chapter 13 Descending inhibitory systems / A. Pertovaara, A. Almeida //Handb Clin Neurol.
– 2006. – Vol.81. – Р.179-92.195.Pertovaara, A. Dissociation of the α2-adrenergic antinociception from sedation followingmicroinjection of medetomidine into the locus coeruleus in rats / A. Pertovaara, M.M. Hаmаlаinen,T. Kauppila [et al.] // Pain. – 1994. – Vol.57. – №2. – Р.207–15.196.Philipp, M. Physiological significance of alpha(2)-adrenergic receptor sub type diversity:one receptor is not enough / M. Philipp, M. Bred, L. Hein // Am. J. Physiol.
Regul. Integr. Comp.Physiol. – 2002. – Vol.283. – №2. – R287–R295.197.Piao, G. Systematic assessment of dexmedetomidine as an anesthetic agent: a meta-analysis of randomized controlled trials / G. Piao, J. Wu // Arch Med Sci. – 2014. – Vol.10. – №1. –Р.19-24.198.Piascik, M.T. Alpha-adrenoceptors and vascular regulation: Molecular, pharmacologic andclinical correlates / M.T. Piascik, E.E. Soltis, M.M. Piascik [et al.] // Pharmacol Ther. – 1996.
–Vol.72. – №3. – P.215-41.199.Raissuni, Z. Can we obtain a noninvasive and continuous estimation of cardiac output?Comparison between three noninvasive methods / Z. Raissuni, F. Zores, O. Henriet [et al.] // Int HeartJ. – 2013. – Vol.54. – №6. – Р.395-400.200.Ramsay, M.A. Controlled sedation with alphaxolone-alphadalone / M.A. Ramsay, T.M.Savege, B.R.
Simpson [et al.] // BMJ. – 1974. – Vol.2. – №5920. – Р.656-9.201.Ramsay, M.A. Tracheal resection in the morbidly obese patient: the role ofdexmedetomidine / M.A. Ramsay, D. Saha, R.F. Hebeler // J Clin Anesth. – 2006. – Vol.18. – №6. –Р.452-4.202.Reddy, S.V. Dexmedetomidine versus esmolol to attenuate the hemodynamic response tolaryngoscopy and tracheal intubation: A randomized double-blind clinical study / S.V. Reddy, D.Balaji, S.N. Ahmed // Int J Appl Basic Med Res.
– 2014. – Vol.4. – №2. – Р.95–100.203.Reddy, S.V. Spinal noradrenergic terminal system mediates antinociception / S.V. Reddy,T.L. Yaksh // Brain Res. – 1980. – Vol.189. – №2. – Р.391-401.112204.Riedl, M.S. Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substanceP-containing terminals in rat dorsal horn / M.S. Riedl, S.A. Schnell, A.C. Overland [et al.] // J CompNeurol. – 2009. – Vol.513. – №4. – Р.385-98.205.Riha, H. Major themes for 2012 in cardiovascular anesthesia and intensive care / H. Riha,P. Patel, L. Al-Ghofaily [et al.] // HSR Proc Intensive Care Cardiovasc Anesth. – 2013.
– Vol.5. –№1. – Р.9-16.206.Roerig, S.C. Spinal interactions between opioid and noradrenergic agonists in mice:multiplicativity involves delta and alpha-2 receptors / S.C. Roerig, S. Lei, K.F. Kitto [et al.] // JPharmacol Exp Ther. – 1992. – Vol.262. – №1. – Р.365–74.207.Rudomin, P. Presynaptic inhibition in the vertebrate spinal cord revisited / P. Rudomin,R.F.
Schmidt // Exp Brain Res. – 1999. – Vol.129. – №1. – Р.1–37.208.Sağıroğlu, A.E. Dıfferent doses of dexmedetomidine on controlling haemodynamicresponses to tracheal intubation / A.E. Sağıroğlu, M. Celik, Z. Orhon [et al.] // Int J Anesthesiol. –2010. – Vol.27. – №2. – Р.1-5.209.Sakamoto, H. Clonidine induces sedation through acting on the perifornical area and thelocus coeruleus in rats / H. Sakamoto, S.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
